INTERNATIONAL PATENT: NAMMI THERAPEUTICS, INC. FILES APPLICATION FOR "FORMULATED AND/OR CO-FORMULATED LIPOSOME COMPOSITIONS CONTAINING TGFB ANTAGONIST PRODRUGS USEFUL IN THE TREATMENT OF CANCER AND METHODS THEREOF"

GENEVA, March 25 -- NAMMI THERAPEUTICS, INC. (10940 Wilshire Blvd.Suite 600Los Angeles, CA 90024) filed a patent application (PCT/US2024/000015) for "FORMULATED AND/OR CO-FORMULATED LIPOSOME COMPOSITIONS CONTAINING TGFB ANTAGONIST PRODRUGS USEFUL IN THE TREATMENT OF CANCER AND METHODS THEREOF" on May 13, 2024. With publication no. WO/2025/058654, the details related to the patent application was published on Mar 20, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): STOVER, David (10786 Ashton AvenueLos Angeles, CA 90024), BHARALI, Dhruba (4519 Cedros AvenueSherman Oaks, CA 91403), HAY, Bruce, ...